Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022

SELL
$19.35 - $35.04 $164,649 - $298,155
-8,509 Closed
0 $0
Q1 2022

May 13, 2022

SELL
$24.62 - $34.31 $53,646 - $74,761
-2,179 Reduced 20.39%
8,509 $282,000
Q4 2021

Feb 11, 2022

BUY
$30.19 - $40.28 $8,634 - $11,520
286 Added 2.75%
10,688 $349,000
Q3 2021

Nov 12, 2021

BUY
$29.09 - $45.68 $302,594 - $475,163
10,402 New
10,402 $436,000
Q1 2020

May 13, 2020

SELL
$21.5 - $54.2 $6.5 Million - $16.4 Million
-302,276 Closed
0 $0
Q4 2019

Feb 12, 2020

SELL
$34.54 - $44.87 $773,696 - $1.01 Million
-22,400 Reduced 6.9%
302,276 $12.4 Million
Q2 2019

Aug 14, 2019

SELL
$42.0 - $59.29 $11.4 Million - $16 Million
-270,600 Reduced 45.46%
324,676 $16.7 Million
Q1 2019

May 14, 2019

SELL
$40.82 - $62.45 $2.65 Million - $4.06 Million
-65,000 Reduced 9.84%
595,276 $34.1 Million
Q4 2018

Feb 12, 2019

BUY
$39.11 - $75.15 $492,786 - $946,890
12,600 Added 1.95%
660,276 $27.7 Million
Q3 2018

Nov 13, 2018

SELL
$65.0 - $82.15 $6.23 Million - $7.87 Million
-95,800 Reduced 12.89%
647,676 $48.9 Million
Q2 2018

Aug 14, 2018

SELL
$27.2 - $74.35 $690,880 - $1.89 Million
-25,400 Reduced 3.3%
743,476 $53.3 Million
Q1 2018

May 10, 2018

SELL
$24.05 - $37.5 $2.45 Million - $3.82 Million
-101,924 Reduced 11.7%
768,876 $23 Million
Q4 2017

Feb 14, 2018

SELL
$26.0 - $34.6 $452,400 - $602,040
-17,400 Reduced 1.96%
870,800 $29 Million
Q3 2017

Nov 13, 2017

BUY
$18.0 - $32.95 $16 Million - $29.3 Million
888,200
888,200 $29.3 Million

Others Institutions Holding RGNX

About REGENXBIO Inc.


  • Ticker RGNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,230,000
  • Market Cap $415M
  • Description
  • REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...
More about RGNX
Track This Portfolio

Track Franklin Resources Inc Portfolio

Follow Franklin Resources Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.